ConductScience.org, home

Trial · NCT03478059

Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI

NCT03478059, Not applicable, Completed, Allina Health System

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI. Trials, record NCT03478059. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03478059

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI
NCT number
NCT03478059
Status
Completed
Phases
Not applicable
Enrollment
24 participants, actual
Lead sponsor
Allina Health System
Conditions
Brain Injury Traumatic Mild, Concussion, Brain
Interventions
Cognitive and Motor Dual-task Intervention
First posted
2018-03-27
Last updated
2019-08-30

Source ClinicalTrials.gov

Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in peak velocity turns during Instrumented Stand and Walk TestAt baseline and after 6 weeks of interventionChange in peak velocity during 180 degree turns during Instrumented Stand and Walk Test in single task (ST) and dual-task (DT) conditions. DT condition involves grid memorization task.
SecondaryChange in peak turning velocity during walking a custom turning courseAt baseline and after 6 weeks of interventionChange in peak turning velocity during walking a custom turning course in ST and DT conditions.
SecondaryChange in peak turning velocity during running an agility courseAt baseline and after 6 weeks of interventionChange in peak turning velocity during running an agility course in ST and DT conditions.
SecondaryChange in medial -lateral (coronal plane) sway area during eyes closed, narrowed stanceAt baseline and after 6 weeks of interventionChange in medial -lateral (coronal plane) sway area during eyes closed, narrowed stance in ST and DT conditions.
SecondaryChange in Beck Depression Inventory-IIAt baseline and after 6 weeks of interventionChange in Beck Depression Inventory-II: 21 item self-administered questionnaire that measures intensity of depression.
SecondaryChange in Beck Anxiety InventoryAt baseline and after 6 weeks of interventionChange in Beck Anxiety Inventory: 21 item self-administered questionnaire measuring subjective, somatic, or panic-related symptoms of anxiety.
SecondaryChange in Patient-specific Functional ScaleAt baseline and after 6 weeks of intervention
Change in Patient-specific Functional Scale -quantifies the amount of functional limitation secondary to symptoms in up to 3 activities that are relevant to the individual patient. 0 to 10 scale, where 0 = unable to perform activity and 10 = able to perform activity at same level as before injury or problem.
SecondaryChange in Neurobehavioral Symptom Inventory (NSI)At baseline and after 6 weeks of interventionChange in Neurobehavioral Symptom Inventory (NSI): Self-report of residual symptoms "in last 2 weeks", a measure of post-TBI symptom severity, 0-4 scale on 22 symptom questions.
SecondaryRey Auditory Verbal Learning Test ScoreAt baselineRey Auditory Verbal Learning Test which measures verbal learning and memory (short-term)
SecondaryComprehensive Trails Making Test ScoreBaselineComprehensive Trails Making Test which measures set shifting, attention, psychomotor speed

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Stroop Color-Word TestSecondary outcomeConductCognition
Verbal FluencySecondary outcomeConductCognition
Verbal LearningSecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03478059

GET https://conductscience.org/api/trials/v1/NCT03478059/registered